BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11127750)

  • 1. Sampling, sampling errors and specimen preparation.
    Baandrup U; Bishop JW; Bonfiglio TA; Branca M; Hutchinson ML; Laverty CR; Ahmad J; Illescas LT; Obwegeser JH; Patnick J; Pogacnik A; Rosenthal DL; Suprun HZ; Verhest A; Richart RM
    Acta Cytol; 2000; 44(6):944-8. PubMed ID: 11127750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell preparation methods and criteria for sample adequacy. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    McGoogan E; Colgan TJ; Ramzy I; Cochand-Priollet B; Davey DD; Grohs HK; Gurley AM; Husain OA; Hutchinson ML; Knesel EA; Linder J; Mango LJ; Mitchell H; Peebles A; Reith A; Robinowitz M; Sauer T; Shida S; Solomon D; Topalidis T; Wilbur DC; Yamauchi K
    Acta Cytol; 1998; 42(1):25-32. PubMed ID: 9479321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory closure of cervical cytology laboratories: recommendations for a public health response.
    MMWR Recomm Rep; 1997 Dec; 46(RR-17):1-19. PubMed ID: 9409538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of false negative Pap smears by rapid reviewing. A metaanalysis.
    Arbyn M; Schenck U
    Acta Cytol; 2000; 44(6):949-57. PubMed ID: 11127751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor.
    Hutchinson ML; Isenstein LM; Goodman A; Hurley AA; Douglass KL; Mui KK; Patten FW; Zahniser DJ
    Am J Clin Pathol; 1994 Feb; 101(2):215-9. PubMed ID: 8116578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct-to-vial use of the AutoCyte PREP liquid-based preparation for cervical-vaginal specimens in three European laboratories.
    Vassilakos P; Saurel J; Rondez R
    Acta Cytol; 1999; 43(1):65-8. PubMed ID: 9987452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening from the public health perspective.
    Steiner C
    Acta Cytol; 1989; 33(4):471-4. PubMed ID: 2750437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Papanicolaou smear histories of 237 patients with cervical cancer.
    Grace J
    Med J Aust; 1992 Sep; 157(5):353. PubMed ID: 1435485
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality assurance in cervical cytology. The Papanicolaou smear. Council on Scientific Affairs.
    JAMA; 1989 Sep 22-29; 262(12):1672-9. PubMed ID: 2671421
    [No Abstract]   [Full Text] [Related]  

  • 10. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
    Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
    Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pap smears. Do them right and every year--forever!
    Gall SA
    Postgrad Med; 1989 May; 85(6):235-9. PubMed ID: 2710727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears.
    Jacobs MV; Zielinski D; Meijer CJ; Pol RP; Voorhorst FJ; de Schipper FA; Runsink AP; Snijders PJ; Walboomers JM
    Br J Cancer; 2000 Apr; 82(8):1421-6. PubMed ID: 10780521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pap smear quality parameters of 3 sampling devices used by auxiliary nurse midwives on symptomatic rural Indian women.
    Rao L; Kamath VK; Boon ME; Valiathan M; Rao AC
    Acta Cytol; 2005; 49(3):249-56. PubMed ID: 15966285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competency assessment and proficiency testing.
    Davey DD; McGoogan E; Somrak TM; Allen KA; Beccati D; Cramer SF; Frable WJ; Hauser NJ; Hewer EM; Lestadi J; Lulla MK; O'Rourke D; Suprun HZ
    Acta Cytol; 2000; 44(6):939-43. PubMed ID: 11127749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of smear quality on the rate of detecting significant cervical cytologic abnormalities.
    Henry JA; Wadehra V
    Acta Cytol; 1996; 40(3):529-35. PubMed ID: 8669190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common problems in Papanicolaou smear interpretation.
    DeMay RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):229-38. PubMed ID: 9111106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
    Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size calculations for rescreening cytologic smears.
    Nagy GK; Collins DN; Wilson TA
    Acta Cytol; 1996; 40(3):501-5. PubMed ID: 8669186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pivotal role of the pathology laboratory in the context of a Singapore cervical cancer screening programme.
    Chang AR
    Singapore Med J; 2004 Jun; 45(6):257-66. PubMed ID: 15181519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The false-negative fraction: a statistical method to measure the efficacy of cervical smear screening laboratories.
    Dolinar J; Ollayos CW; Tellado M; Ali I; Stevens A; Paquette C; Brodbelt S
    Mil Med; 1999 Jun; 164(6):410-1. PubMed ID: 10377709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.